TY - JOUR
AB - To the Editor: Wright et al. (Nov. 26 issue)1 report on the Systolic Blood Pressure Intervention Trial (SPRINT). By focusing on blood-pressure levels, rather than on specific antihypertensive agents, this trial follows a rich heritage of government-funded, noncommercial, randomized trials in hypertension that address major public health issues. The clear differences in outcomes, including lower rates of death among patients who were randomly assigned to intensive treatment than among those assigned to standard treatment, underscore the major impact of implementing this lower blood-pressure target for the appropriate population. Achievement of a difference of 15 mm Hg between patients who were . . .
TI - A Randomized Trial of Intensive versus Standard Blood-Pressure Control
JF - The New England Journal of Medicine
DO - 10.1056/NEJMc1602668
DA - 2016-06-09
UR - https://www.deepdyve.com/lp/the-new-england-journal-of-medicine/a-randomized-trial-of-intensive-versus-standard-blood-pressure-control-SvWa8Xt21O
SP - 2290
EP - 2295
VL - 374
IS - 23
DP - DeepDyve
ER -